Professor of Cancer Therapeutics
University of Cambridge
Professor of Cancer Therapeutics, University of Cambridge.
Senior Group Leader and Head of the Pharmacology and Drug Development Group at the Cancer Research UK Cambridge Institute.
Cambridge Experimental Cancer Medicine Centre (ECMC) Lead for Early Phase Trials
Honorary consultant at Addenbrookes Hospital.
Duncan is a fully trained and accredited Medical Oncologist. Since moving to Cambridge, he has been instrumental in establishing the specialist oncology clinic for patients with pancreatic cancer (in 2009), which, together with his research activity in cancer therapeutics were major factors in Cambridge’s successful application to become the Regional Centre for Pancreatic Cancer (in 2010). As the Cambridge ECMC Lead for Early Phase Trials, he manages a research team and clinic, allowing patients across the Anglia region to access new therapies for cancer.
As a Senior Group Leader in the Cancer Research UK Cambridge Institute, Duncan undertakes research into new therapies for patients with cancer. He also collaborates closely with imaging specialists in both the Institute and Addenbrookes Hospital, incorporating novel molecular imaging approaches into Early Phase trials of cancer therapeutics.
Co-Lead Pre-Clinical Therapeutics
Contributor: Research, Clinical Trials
Specialist knowledge: Clinical trials, experimental therapeutics, combination approaches, molecular imaging, pharmacokinetics